Centre for Personalised Molecular Immunotherapy (Q3298146): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations) |
(Changed label, description and/or aliases in it, and other parts: Adding Italian translations) |
||||||||||||||
| label / it | label / it | ||||||||||||||
Centro per l'immunoterapia molecolare personalizzata | |||||||||||||||
| Property / summary | |||||||||||||||
Stretta collaborazione con i partner del settore per sviluppare nuovi anticorpi e terapie tumorali efficienti. (Italian) | |||||||||||||||
| Property / summary: Stretta collaborazione con i partner del settore per sviluppare nuovi anticorpi e terapie tumorali efficienti. (Italian) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Stretta collaborazione con i partner del settore per sviluppare nuovi anticorpi e terapie tumorali efficienti. (Italian) / qualifier | |||||||||||||||
point in time: 18 January 2022
| |||||||||||||||
Revision as of 20:49, 18 January 2022
Project Q3298146 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Centre for Personalised Molecular Immunotherapy |
Project Q3298146 in Germany |
Statements
5,037,747.0 Euro
0 references
18 October 2016
0 references
31 October 2021
0 references
Universität Würzburg
0 references
50°1'21.29"N, 9°53'30.62"E
0 references
Enge Kooperation mti Industriepartnern zur Entwicklung neuer effizienter Antikörper und Tumortherapien. (German)
0 references
Close cooperation with industry partners to develop new efficient antibodies and tumor therapies. (English)
24 October 2021
0 references
Coopération étroite avec les partenaires industriels pour le développement de nouveaux anticorps efficaces et thérapies tumorales. (French)
6 December 2021
0 references
Nauwe samenwerking met partners uit de industrie om nieuwe efficiënte antilichamen en tumortherapieën te ontwikkelen. (Dutch)
19 December 2021
0 references
Stretta collaborazione con i partner del settore per sviluppare nuovi anticorpi e terapie tumorali efficienti. (Italian)
18 January 2022
0 references
Unterfranken
0 references
Identifiers
DE_TEMPORARY_944
0 references